Assertio said Dec. 12 it will sell its shingles pain drug, Gralise, to Alvogen for $127.5 million. Under the agreement, Alvogen will pay Assertio $75 million when the sale closes and the remainder as ...
SEATTLE — Washington state may receive more than $16 million as part of $720 million in nationwide settlements announced Tuesday with eight pharmaceutical companies accused of contributing to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback